Supplementary Figure 1.tif (41.56 kB)

nnm-2021-0164 - Supplementary Figure 1

figure

posted on 2021-09-16, 09:28 authored by Amanda de Fraga Dias, Danieli Rosane Dallemole, Franciele Aline Bruinsmann, Luiz Fernando Lopes Silva, Olga Cruz-López, Ana Conejo-García, Ana Maria Oliveira Battastini, Joaquín María Campos, Silvia Stanisçuaski Guterres, Adriana Raffin Pohlmann, Fabrício Figueiró

Supplementary Figure 1. Particle size by relative light intensity for the LNC⁺ (light green) and BZP-LNC⁺ (dark green).

Funding

Funding This study is supported by CNPq (AF Dias fellowship and CNPq/PQ no. 302879/2017-0, AMO Battastini grant), FAPERGS (FAPERGS/PQG grant no. 19/2551-0001783-9; ARD grant no. 19/2551-0001269-1 and PRONEX no. 16-2551-0000467-6) and INCT/CNPq/CAPES/ FAPERGS grant no. 465671/2014-4).

History

Usage metrics

Read the peer-reviewed publication

Development of bozepinib-loaded nanocapsules for nose-to-brain delivery: preclinical evaluation in glioblastoma

Categories

Keywords

Glioblastoma bozepinib temozolomide lipid-core nanocapsules drug delivery intranasal Central Nervous System Cancer Therapy (excl. Chemotherapy and Radiation Therapy)

Licence

CC BY-NC-ND 4.0

Exports